Jan Bogeholz
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.
Journal: Research square
Published: November 24, 2025
Detection of Scedosporium spp.: Colonizer or pathogen? A retrospective analysis of clinical significance and management in a large tertiary center.
Journal: Medical mycology
Published: November 16, 2023
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
Journal: Nature
Published: December 19, 2022
Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
Journal: Transplantation and cellular therapy
Published: September 12, 2021
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients.
Journal: Inflammatory intestinal diseases
Published: March 31, 2020
Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect.
Journal: BMC cancer
Published: July 22, 2019
Long-Term Follow-Up of Antibody Titers Against Measles, Mumps, and Rubella in Recipients of Allogenic Hematopoietic Cell Transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: July 15, 2019
Targeting CD157 in AML using a novel, Fc-engineered antibody construct.
Journal: Oncotarget
Published: November 01, 2016
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.
Journal: Blood
Published: December 05, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026